Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Dexamethasone/pomalidomide

Various toxicities: 2 case reports

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Mele G, et al. Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'. Leukemia and Lymphoma 60: 3565-3568, No. 14, Dec 2019. Available from: URL: http://doi.org/10.1080/10428194.2019.1636989

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Dexamethasone/pomalidomide. Reactions Weekly 1790, 96 (2020). https://doi.org/10.1007/s40278-020-74715-y

    Download citation